BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 33894441)

  • 1. Prognostic significance of peripheral blood monocyte and neutrophil counts in rheumatoid arthritis-associated interstitial lung disease.
    Saku A; Fujisawa T; Nishimoto K; Yoshimura K; Hozumi H; Karayama M; Suzuki Y; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
    Respir Med; 2021 Jun; 182():106420. PubMed ID: 33894441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease.
    Tyker A; Ventura IB; Lee CT; Strykowski R; Garcia N; Guzy R; Jablonski R; Vij R; Strek ME; Chung JH; Adegunsoye A
    Sci Rep; 2021 Nov; 11(1):22821. PubMed ID: 34819525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
    Solomon JJ; Ryu JH; Tazelaar HD; Myers JL; Tuder R; Cool CD; Curran-Everett D; Fischer A; Swigris JJ; Brown KK
    Respir Med; 2013 Aug; 107(8):1247-52. PubMed ID: 23791462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet/Lymphocyte, Lymphocyte/Monocyte, and Neutrophil/Lymphocyte Ratios as Biomarkers in Patients with Rheumatoid Arthritis and Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Chen Q; Chen DY; Xu XZ; Liu YY; Yin TT; Li D
    Med Sci Monit; 2019 Aug; 25():6474-6481. PubMed ID: 31462627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characteristics associated with occurrence and poor prognosis of interstitial lung disease in rheumatoid arthritis.
    Yang JA; Lee JS; Park JK; Lee EB; Song YW; Lee EY
    Korean J Intern Med; 2019 Mar; 34(2):434-441. PubMed ID: 28352064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrocyte measurement in peripheral blood correlates with number of cultured mature fibrocytes in vitro and is a potential biomarker for interstitial lung disease in Rheumatoid Arthritis.
    Just SA; Lindegaard H; Hejbøl EK; Davidsen JR; Bjerring N; Hansen SWK; Schrøder HD; Hansen IMJ; Barington T; Nielsen C
    Respir Res; 2017 Jul; 18(1):141. PubMed ID: 28720095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are risk predicting models useful for estimating survival of patients with rheumatoid arthritis-associated interstitial lung disease?
    Nurmi HM; Purokivi MK; Kärkkäinen MS; Kettunen HP; Selander TA; Kaarteenaho RL
    BMC Pulm Med; 2017 Jan; 17(1):16. PubMed ID: 28086844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease.
    Li L; Liu R; Zhang Y; Zhou J; Li Y; Xu Y; Gao S; Zheng Y
    Clin Rheumatol; 2020 May; 39(5):1457-1470. PubMed ID: 31858341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of blood KL-6 in rheumatoid arthritis-associated interstitial lung disease.
    Kim HC; Choi KH; Jacob J; Song JW
    PLoS One; 2020; 15(3):e0229997. PubMed ID: 32163457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for progression and prognosis of rheumatoid arthritis-associated interstitial lung disease: single center study with a large sample of Chinese population.
    Fu Q; Wang L; Li L; Li Y; Liu R; Zheng Y
    Clin Rheumatol; 2019 Apr; 38(4):1109-1116. PubMed ID: 30535993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with mortality in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
    Qiu M; Jiang J; Nian X; Wang Y; Yu P; Song J; Zou S
    Respir Res; 2021 Oct; 22(1):264. PubMed ID: 34635095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease.
    Wan J; Yu Z; Cao X; Zhao X; Zhou W; Zheng Y
    Clin Rheumatol; 2024 Jun; 43(6):1855-1863. PubMed ID: 38704780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and quality of life in rheumatoid arthritis-associated interstitial lung disease after lung transplantation.
    Yazdani A; Singer LG; Strand V; Gelber AC; Williams L; Mittoo S
    J Heart Lung Transplant; 2014 May; 33(5):514-20. PubMed ID: 24630861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of mortality in rheumatoid arthritis-related interstitial lung disease.
    Assayag D; Lubin M; Lee JS; King TE; Collard HR; Ryerson CJ
    Respirology; 2014 May; 19(4):493-500. PubMed ID: 24372981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of distinct peripheral blood myeloid cell subpopulations in patients with rheumatoid arthritis-associated interstitial lung disease.
    Poole JA; Cole KE; Thiele GM; Talmadge JE; England BR; Nelson AJ; Gleason A; Schwab A; Gaurav R; Duryee MJ; Bailey KL; Romberger DJ; Hershberger D; De Graaff JV; May SM; Walenz R; Kramer B; Mikuls TR
    Int Immunopharmacol; 2024 Jan; 127():111330. PubMed ID: 38086271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid Arthritis-Associated Interstitial Lung Disease: Clinical Characteristics and Predictors of Mortality.
    Hyldgaard C; Ellingsen T; Hilberg O; Bendstrup E
    Respiration; 2019; 98(5):455-460. PubMed ID: 31597131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Value of Biomarkers as Predictors of Outcome in Patients with Rheumatoid Arthritis-Associated Usual Interstitial Pneumonia.
    Lee YS; Kim HC; Lee BY; Lee CK; Kim MY; Jang SJ; Lee HS; Moon J; Colby TV; Kim DS
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):216-223. PubMed ID: 27758986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble programmed death molecule 1 (sPD-1) as a predictor of interstitial lung disease in rheumatoid arthritis.
    Xu L; Jiang L; Nie L; Zhang S; Liu L; Du Y; Xue J
    BMC Immunol; 2021 Oct; 22(1):69. PubMed ID: 34654367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers of rheumatoid arthritis-associated interstitial lung disease.
    Chen J; Doyle TJ; Liu Y; Aggarwal R; Wang X; Shi Y; Ge SX; Huang H; Lin Q; Liu W; Cai Y; Koontz D; Fuhrman CR; Golzarri MF; Liu Y; Hatabu H; Nishino M; Araki T; Dellaripa PF; Oddis CV; Rosas IO; Ascherman DP
    Arthritis Rheumatol; 2015 Jan; 67(1):28-38. PubMed ID: 25302945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The serum level and significance of lysyl oxidase-like 2 in patients with rheumatoid arthritis-associated interstitial lung disease.
    Fu Q; Bai Y; Liu Y; Zhou J; Zheng Y
    Clin Rheumatol; 2018 Jan; 37(1):193-198. PubMed ID: 29052023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.